| Insideraktier | 36.510.486 shares |
Insider-stemningsscore
Insider Sentiment Score viser, at virksomhederne bliver købt af virksomheders insidere.
Det er resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af insider-akkumulering. Scoringsmodellen bruger en kombination af nettoantallet af insidere, der har købt de foregående 90 dage, det samlede antal aktier købt som en procentdel af float og det samlede antal aktier ejet af insidere. Tallet går fra 0 til 100, hvor højere tal indikerer et højere niveau af akkumulering for sine jævnaldrende, og 50 er gennemsnittet.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med den højeste insider-akkumulering.
Officers sentiment score
Officer Sentiment Score finder virksomheder, der bliver købt af Corporate Officers.
Per definition er Corporate Officers Corporate Insiders, men i modsætning til nogle af de andre Insiders (10 % aktionærer og bestyrelsesmedlemmer), arbejder officerer for virksomheden på daglig basis, og de bruger deres egne penge, når de handler . (10 % aktionærer og bestyrelsesmedlemmer er ofte fondsforvaltere, der administrerer andres penge.) Som sådan er insiderhandler foretaget af embedsmænd meget mere betydningsfulde og bør behandles passende.
Ligesom Insider Sentiment Score er Officer Sentiment Score resultatet af en sofistikeret, multi-faktor kvantitativ model, der identificerer virksomheder med de højeste niveauer af officerakkumulering.
Opdateringsfrekvens: Dagligt
Se Insiders Top Picks, som giver en liste over virksomheder med højeste insider-stemning.
Nøgle Insider Metrics
Dette kort viser, hvordan virksomheden rangerer langs forskellige insider-metrics. Percentilrangen viser, hvordan denne virksomhed sammenligner sig med andre virksomheder på de amerikanske markeder. Højere placeringer er tegn på bedre situationer.
For eksempel er det generelt accepteret, at insider-køb er en positiv indikator, så virksomheder med flere insider-køb vil rangere højere end virksomheder med mindre insider-køb (eller endda insider-salg).
Netto antal insidere, der køber (rang)
N/A
Netto antal insidere, der køber, er det samlede antal insiders, der køber minus det samlede antal insiders, der har solgt inden for de sidste 90 dage. Percentilrangen vises her (spænder fra 0 til 100%).
Procent af float købt af insidere (rangering)
N/A
Procent af float købt af insidere er det samlede antal aktier købt af insidere minus det samlede antal aktier solgt af insidere inden for de sidste 90 dage, divideret med den samlede float og ganget med 100.
Insiderhandelsdiagram
Stablecoin Development Corporation insiderhandler er vist i følgende diagram. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Generelt er det generelt ulovligt for insidere at foretage handler i deres virksomheder baseret på væsentlige, ikke-offentlige oplysninger. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4.
Insiderliste og lønsomhedsmålinger
Denne tabel viser listen over kendte insidere og genereres automatisk fra arkiveringer, der er videregivet til SEC. Ud over navnene, den seneste titel og direktør, officer eller 10 % ejerbetegnelse giver vi de seneste offentliggjorte besiddelser. Derudover giver vi, når det er muligt, den historiske handelspræstation for insideren. Den historiske handelspræstation er et vægtet gennemsnit af præstationen af faktiske købstransaktioner på det åbne marked foretaget af insideren. For mere information om, hvordan dette beregnes, se dette YouTube-webinar.
See our leaderboard of most profitable insider traders.
| Insider | Gennemsnitlig fortjeneste (%) | Aktier Ejet |
Dele Justeret |
|---|
Report errors via our new Insider Auditing Tool
Track Records af insiderkøb - Kortsigtet profitanalyse
I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i NBY / Stablecoin Development Corporation. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Track Records af insidersalg - Kortsigtet tabsanalyse
I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i NBY / Stablecoin Development Corporation. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .
Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.
Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.
Transaktionshistorik
Klik på linkikonet for at se den fulde transaktionshistorik. Transaktioner, der rapporteres som en del af en automatisk handelsplan 10b5-1, vil have et X i kolonnen markeret 10b-5.
| Fil Dato |
Handle Dato |
Form | Insider | Ticker | Sikkerhedstitel | Kode | Direkte | Dyrke motion Pris |
Enhed Pris |
Enheder Ændret |
Værdi Ændret (1K) |
Tilbage Muligheder |
Tilbage Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-04-30 | 2025-10-21 | 4/A | Kazley Michael John By R01 Entities | SDEV | Common Stock | I | 11.361.216 | 11.361.216 | ||||||
| 2026-04-30 | 2025-10-21 | 4/A | Framework Ventures IV L.P. | SDEV | Common Stock | D | 11.361.216 | 11.361.216 | ||||||
| 2026-04-30 | 2025-10-21 | 4/A | R01 Fund LP | SDEV | Common Stock | D | 11.361.216 | 11.361.216 | ||||||
| 2026-01-29 | 2025-10-21 | 4 | Lazar David E. | NBY | Common Stock | D | 6.388.000 | 6.388.000 | ||||||
| 2025-11-03 | 2025-10-21 | 4 | Kazley Michael John By R01 Entities | NBY | Common Stock | I | 56.806.080 | 56.806.080 | ||||||
| 2025-11-03 | 2025-10-21 | 4 | R01 Fund LP | NBY | Common Stock | D | 56.806.080 | 56.806.080 | ||||||
| 2025-11-03 | 2025-10-21 | 4 | Framework Ventures IV L.P. | NBY | Common Stock | D | 56.806.080 | 56.806.080 | ||||||
| 2025-08-26 | 3 | Lazar David E. | NBY | Common Stock | D | 0 | ||||||||
| 2025-04-15 | 2025-04-08 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,4650 | 300 | 0 | 1.020.300 | ||||
| 2025-04-15 | 2025-04-04 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,5216 | 4.538 | 2 | 1.020.000 | ||||
| 2025-04-15 | 2025-04-03 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,5627 | 22.976 | 13 | 1.015.462 | ||||
| 2025-04-15 | 2025-04-02 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,5800 | 917 | 1 | 992.486 | ||||
| 2025-04-15 | 2025-04-01 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,5850 | 19.915 | 12 | 991.569 | ||||
| 2025-04-15 | 2025-03-31 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,5900 | 21.654 | 13 | 971.654 | ||||
| 2025-04-15 | 2025-03-28 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6124 | 49.400 | 30 | 950.000 | ||||
| 2025-04-15 | 2025-03-27 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6090 | 600 | 0 | 900.600 | ||||
| 2025-04-15 | 2025-03-27 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6150 | 18.504 | 11 | 900.000 | ||||
| 2025-04-15 | 2025-03-26 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6090 | 13.292 | 8 | 881.496 | ||||
| 2025-04-15 | 2025-03-25 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6100 | 22.635 | 14 | 868.204 | ||||
| 2025-04-15 | 2025-03-24 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6050 | 100 | 0 | 845.569 | ||||
| 2025-04-15 | 2025-03-21 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6050 | 6.372 | 4 | 845.469 | ||||
| 2025-04-15 | 2025-03-20 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6149 | 5.320 | 3 | 839.097 | ||||
| 2025-04-15 | 2025-03-19 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6025 | 1.500 | 1 | 833.777 | ||||
| 2025-04-15 | 2025-03-18 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6300 | 14.000 | 9 | 832.277 | ||||
| 2025-04-15 | 2025-03-18 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6300 | 10.000 | 6 | 818.277 | ||||
| 2025-04-15 | 2025-03-14 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6300 | 25.511 | 16 | 808.277 | ||||
| 2025-04-15 | 2025-03-13 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6350 | 34 | 0 | 782.766 | ||||
| 2025-04-15 | 2025-03-12 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6226 | 11.837 | 7 | 782.732 | ||||
| 2025-04-15 | 2025-03-11 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,5800 | 2.148 | 1 | 770.895 | ||||
| 2025-04-15 | 2025-03-10 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,5800 | 14.645 | 8 | 768.747 | ||||
| 2025-04-15 | 2025-03-07 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,5500 | 102 | 0 | 754.102 | ||||
| 2025-04-15 | 2025-03-04 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,5784 | 4.000 | 2 | 754.000 | ||||
| 2025-04-15 | 2025-02-28 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6020 | 13.108 | 8 | 750.000 | ||||
| 2025-04-15 | 2025-02-27 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6100 | 385 | 0 | 736.892 | ||||
| 2025-04-15 | 2025-02-26 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6100 | 6.302 | 4 | 736.507 | ||||
| 2025-04-15 | 2025-02-25 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6199 | 25.033 | 16 | 730.205 | ||||
| 2025-04-15 | 2025-02-24 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6200 | 450 | 0 | 705.172 | ||||
| 2025-04-15 | 2025-02-20 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6300 | 1.836 | 1 | 704.722 | ||||
| 2025-04-15 | 2025-02-19 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6715 | 49.664 | 33 | 702.886 | ||||
| 2025-04-15 | 2025-02-18 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6600 | 3.222 | 2 | 653.222 | ||||
| 2025-04-15 | 2025-02-04 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6350 | 26.718 | 17 | 650.000 | ||||
| 2025-04-15 | 2025-02-03 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6350 | 2.597 | 2 | 623.282 | ||||
| 2025-04-15 | 2025-01-31 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6483 | 70.685 | 46 | 620.685 | ||||
| 2025-04-15 | 2025-01-27 | 4 | POPLAR POINT CAPITAL PARTNERS LP | NBY | Common Stock, par value $0.01 per share | D | 0,6900 | 31.703 | 22 | 550.000 | ||||
| 2025-04-07 | 3 | POPLAR POINT CAPITAL PARTNERS LP | NBY | COMMON STOCK, PAR VALUE $0.01 | D | 518.297 | ||||||||
| 2023-05-15 | 2023-05-11 | 4 | Freiman Paul E. | NBY | Common Stock | D | 858 | 1.716 | ||||||
| 2023-05-15 | 2023-05-11 | 4 | Zheng Yenyou | NBY | Common Stock | D | 858 | 1.716 | ||||||
| 2023-05-15 | 2023-05-11 | 4 | Zheng Yongxiang | NBY | Common Stock | D | 858 | 858 | ||||||
| 2023-05-15 | 2023-05-11 | 4 | Sit Swan | NBY | Common Stock | D | 858 | 1.716 | ||||||
| 2023-05-15 | 2023-05-11 | 4 | Garlikov Julie | NBY | Common Stock | D | 858 | 858 | ||||||
| 2023-05-15 | 2023-05-11 | 4 | WU MIJIA | NBY | Common Stock | D | 858 | 1.716 | ||||||
| 2023-02-24 | 3 | Law Tommy | NBY | Common Stock | D | 0 | ||||||||
| 2022-12-07 | 2022-12-06 | 4 | Kunin Jeffrey | NBY | Common Stock | I | 1,8100 | -1 | -0 | 0 | ||||
| 2022-12-07 | 2022-12-06 | 4 | Kunin Audrey | NBY | Common Stock | I | 1,8100 | -1 | -0 | 0 | ||||
| 2022-12-05 | 2022-11-21 | 4/A | Kunin Jeffrey | NBY | Common Stock | I | 2,1049 | -5.960 | -13 | 1 | ||||
| 2022-12-05 | 2022-11-21 | 4/A | Kunin Audrey | NBY | Common Stock | I | 2,1049 | -5.960 | -13 | 1 | ||||
| 2022-11-23 | 2022-11-21 | 4 | Kunin Jeffrey | NBY | Common Stock | I | 2,1049 | -5.960 | -13 | 0 | ||||
| 2022-11-23 | 2022-11-21 | 4 | Kunin Audrey | NBY | Common Stock | I | 2,1049 | -5.960 | -13 | 0 | ||||
| 2022-09-16 | 2022-09-14 | 4 | Hall Justin | NBY | Common Stock | D | 0,1500 | 10.000 | 2 | 83.172 | ||||
| 2022-09-16 | 2022-09-14 | 4 | Kunin Jeffrey | NBY | Common Stock | I | 0,1582 | -291.368 | -46 | 208.632 | ||||
| 2022-09-16 | 2022-09-14 | 4 | Kunin Audrey | NBY | Common Stock | I | 0,1582 | -291.368 | -46 | 208.632 | ||||
| 2022-05-24 | 2022-05-21 | 4 | WU MIJIA | NBY | Restricted Stock Units | D | -30.000 | 30.000 | ||||||
| 2022-05-24 | 2022-05-21 | 4 | WU MIJIA | NBY | Common Stock | D | 30.000 | 30.000 | ||||||
| 2022-05-24 | 2022-05-21 | 4 | Zheng Yenyou | NBY | Restricted Stock Units | D | -30.000 | 30.000 | ||||||
| 2022-05-24 | 2022-05-21 | 4 | Zheng Yenyou | NBY | Common Stock | D | 30.000 | 30.000 | ||||||
| 2022-05-24 | 2022-05-21 | 4 | Freiman Paul E. | NBY | Restricted Stock Units | D | -30.000 | 30.000 | ||||||
| 2022-05-24 | 2022-05-21 | 4 | Freiman Paul E. | NBY | Common Stock | D | 30.000 | 30.000 | ||||||
| 2022-05-24 | 2022-05-21 | 4 | Sit Swan | NBY | Restricted Stock Units | D | -30.000 | 30.000 | ||||||
| 2022-05-24 | 2022-05-21 | 4 | Sit Swan | NBY | Common Stock | D | 30.000 | 30.000 | ||||||
| 2022-05-13 | 2022-05-11 | 4 | Zheng Yenyou | NBY | Restricted Stock Units | D | 30.000 | 30.000 | ||||||
| 2022-05-13 | 2022-05-11 | 4 | Sit Swan | NBY | Restricted Stock Units | D | 30.000 | 30.000 | ||||||
| 2022-05-13 | 2022-05-11 | 4 | Zheng Yongxiang | NBY | Restricted Stock Units | D | 30.000 | 30.000 | ||||||
| 2022-05-13 | 2022-05-11 | 4 | WU MIJIA | NBY | Restricted Stock Units | D | 30.000 | 30.000 | ||||||
| 2022-05-13 | 2022-05-11 | 4 | Garlikov Julie | NBY | Restricted Stock Units | D | 30.000 | 30.000 | ||||||
| 2022-05-13 | 2022-05-11 | 4 | Freiman Paul E. | NBY | Restricted Stock Units | D | 30.000 | 30.000 | ||||||
| 2022-02-10 | 3 | Zheng Yongxiang | NBY | Common Stock | D | 0 | ||||||||
| 2022-02-03 | 3 | Garlikov Julie | NBY | Common Stock | D | 0 | ||||||||
| 2021-12-07 | 2021-12-03 | 4 | Kunin Jeffrey | NBY | Common Stock | I | 0,4625 | 101.650 | 47 | 500.000 | ||||
| 2021-12-07 | 2021-12-03 | 4 | Kunin Audrey | NBY | Common Stock | I | 0,4625 | 101.650 | 47 | 500.000 | ||||
| 2021-12-06 | 2021-12-06 | 4 | Hall Justin | NBY | Common Stock | D | 0,4300 | 69.767 | 30 | 73.172 | ||||
| 2021-12-06 | 2021-12-02 | 4 | Kunin Jeffrey | NBY | Common Stock | I | 0,4760 | 262.369 | 125 | 398.350 | ||||
| 2021-12-06 | 2021-12-06 | 4 | Jones Andrew D. | NBY | Common Stock | D | 0,4400 | 36.765 | 16 | 127.461 | ||||
| 2021-12-06 | 2021-12-03 | 4 | Jones Andrew D. | NBY | Common Stock | D | 0,4400 | 8.690 | 4 | 90.696 | ||||
| 2021-12-06 | 2021-12-02 | 4 | Kunin Audrey | NBY | Common Stock | I | 0,4760 | 262.369 | 125 | 398.350 | ||||
| 2021-12-03 | 2021-12-01 | 4 | Kunin Audrey | NBY | Common Stock | I | 0,4900 | 14.848 | 7 | 135.981 | ||||
| 2021-12-03 | 2021-12-01 | 4 | Kunin Jeffrey | NBY | Common Stock | I | 0,4900 | 14.848 | 7 | 135.981 | ||||
| 2021-12-02 | 2021-11-30 | 4 | Kunin Jeffrey | NBY | Common Stock | I | 0,4600 | 30.000 | 14 | 121.133 | ||||
| 2021-12-02 | 2021-11-30 | 4 | Kunin Audrey | NBY | Common Stock | I | 0,4600 | 30.000 | 14 | 121.133 | ||||
| 2021-11-24 | 2021-11-23 | 4 | Kunin Jeffrey | NBY | Common Stock | I | 0,4592 | 66.133 | 30 | 91.133 | ||||
| 2021-11-24 | 2021-11-22 | 4 | Kunin Jeffrey | NBY | Common Stock | I | 0,4600 | 25.000 | 12 | 25.000 | ||||
| 2021-11-24 | 2021-11-23 | 4 | Kunin Audrey | NBY | Common Stock | I | 0,4592 | 66.133 | 30 | 91.133 | ||||
| 2021-11-24 | 2021-11-22 | 4 | Kunin Audrey | NBY | Common Stock | I | 0,4600 | 25.000 | 12 | 25.000 | ||||
| 2021-11-17 | 3 | Kunin Jeffrey | NBY | Common Stock | D | 0 | ||||||||
| 2021-11-17 | 3 | Kunin Audrey | NBY | Common Stock | D | 0 | ||||||||
| 2021-05-25 | 2021-05-21 | 4 | Zheng Yenyou | NBY | Restricted Stock Unit | D | 30.000 | 30.000 | ||||||
| 2021-05-25 | 2021-05-21 | 4 | Li Xinzhou | NBY | Restricted Stock Unit | D | 30.000 | 30.000 | ||||||
| 2021-05-25 | 2021-05-21 | 4 | Sit Swan | NBY | Restricted Stock Unit | D | 30.000 | 30.000 | ||||||
| 2021-05-25 | 2021-05-21 | 4 | WU MIJIA | NBY | Restricted Stock Unit | D | 30.000 | 30.000 | ||||||
| 2021-05-25 | 2021-05-21 | 4 | Freiman Paul E. | NBY | Restricted Stock Unit | D | 30.000 | 30.000 | ||||||
| 2021-05-07 | 2021-05-04 | 4 | Jones Andrew D. | NBY | Common Stock | D | 0,7928 | -77.994 | -62 | 82.006 | ||||
| 2020-08-24 | 2020-08-20 | 4 | Hall Justin | NBY | Stock Option (right to buy) | D | 0,99 | 350.000 | 350.000 | |||||
| 2020-08-24 | 2020-08-20 | 4 | Jones Andrew D. | NBY | Stock Option (right to buy) | D | 0,99 | 25.000 | 25.000 | |||||
| 2020-08-24 | 2020-08-20 | 4 | Xu Wang | NBY | Stock Option (right to buy) | D | 0,99 | 75.000 | 75.000 | |||||
| 2020-08-19 | 2020-08-17 | 4 | WU MIJIA | NBY | Stock Option (right to buy) | D | 0,30 | -20.000 | 0 | |||||
| 2020-08-19 | 2020-08-17 | 4 | WU MIJIA | NBY | Common stock | D | 1,3500 | -20.000 | -27 | 0 | ||||
| 2020-08-19 | 2020-08-17 | 4 | WU MIJIA | NBY | Common stock | D | 0,3000 | 20.000 | 6 | 20.000 | ||||
| 2020-08-04 | 2020-08-01 | 4 | Fu Jian Ping | NBY | Common Stock | D | 1,2300 | -1.302.350 | -1.602 | 4.000.000 | ||||
| 2020-05-29 | 2020-05-26 | 4 | Sit Swan | NBY | Stock option (right to buy) | D | 0,89 | 20.000 | 20.000 | |||||
| 2020-05-29 | 2020-05-26 | 4 | Freiman Paul E. | NBY | Stock option (right to buy) | D | 0,89 | 20.000 | 20.000 | |||||
| 2020-05-29 | 2020-05-26 | 4 | Wang Xiaopei | NBY | Stock option (right to buy) | D | 0,89 | 20.000 | 20.000 | |||||
| 2020-05-29 | 2020-05-26 | 4 | Li Xinzhou | NBY | Stock option (right to buy) | D | 0,89 | 20.000 | 20.000 | |||||
| 2020-05-29 | 2020-05-26 | 4 | Zheng Yenyou | NBY | Stock option (right to buy) | D | 0,89 | 20.000 | 20.000 | |||||
| 2020-05-29 | 2020-05-26 | 4 | WU MIJIA | NBY | Stock option (right to buy) | D | 0,89 | 20.000 | 20.000 | |||||
| 2020-05-13 | 3 | Jones Andrew D. | NBY | Common Stock | D | 320.000 | ||||||||
| 2020-05-13 | 3 | Jones Andrew D. | NBY | Common Stock | D | 320.000 | ||||||||
| 2020-05-13 | 3 | Jones Andrew D. | NBY | Common Stock | D | 320.000 | ||||||||
| 2020-03-19 | 3 | Xu Wang By Spouse | NBY | Common Stock | I | 42.000 | ||||||||
| 2020-03-19 | 3 | Xu Wang By Spouse | NBY | Common Stock | I | 42.000 | ||||||||
| 2020-03-19 | 3 | Xu Wang By Spouse | NBY | Common Stock | I | 42.000 | ||||||||
| 2020-01-28 | 3 | Sit Swan | NBY | Common Stock | D | 0 | ||||||||
| 2019-12-18 | 3 | Wang Xiaopei | NBY | Common Stock | D | 0 | ||||||||
| 2019-10-30 | 2019-05-30 | 4 | Zavodnick Todd Erik | NBY | Stock option (right to buy) | D | 0,30 | 20.000 | 20.000 | |||||
| 2019-10-28 | 2019-06-10 | 4/A | Hall Justin | NBY | Stock Option (right to buy) | D | 2,02 | -47.500 | 0 | |||||
| 2019-10-28 | 2019-06-10 | 4/A | Hall Justin | NBY | Common Stock | D | 3,0300 | -47.500 | -144 | 3.405 | ||||
| 2019-10-28 | 2019-06-10 | 4/A | Hall Justin | NBY | Common Stock | D | 2,0200 | 47.500 | 96 | 50.905 | ||||
| 2019-10-28 | 2019-06-11 | 4/A | Raleigh Jason Philip | NBY | Stock Option (right to buy) | D | 2,35 | -9.750 | 0 | |||||
| 2019-10-28 | 2019-06-11 | 4/A | Raleigh Jason Philip | NBY | Common Stock | D | 3,7500 | -9.750 | -37 | 0 | ||||
| 2019-10-28 | 2019-06-11 | 4/A | Raleigh Jason Philip | NBY | Common Stock | D | 2,3500 | 9.750 | 23 | 9.750 | ||||
| 2019-10-28 | 2019-06-10 | 4/A | Raleigh Jason Philip | NBY | Stock Option (right to buy) | D | 2,20 | -23.405 | 0 | |||||
| 2019-10-28 | 2019-06-10 | 4/A | Raleigh Jason Philip | NBY | Common Stock | D | 3,0000 | -23.405 | -70 | 0 | ||||
| 2019-10-28 | 2019-06-10 | 4/A | Raleigh Jason Philip | NBY | Common Stock | D | 2,2000 | 23.405 | 51 | 23.405 | ||||
| 2019-10-28 | 2019-05-30 | 4 | Freiman Paul E. | NBY | Stock option (right to buy) | D | 0,30 | 20.000 | 20.000 | |||||
| 2019-10-28 | 2019-05-30 | 4 | SIECZKAREK MARK M | NBY | Stock option (right to buy) | D | 0,30 | 20.000 | 20.000 | |||||
| 2019-10-28 | 2019-05-30 | 4 | Maderis Gail J | NBY | Stock option (right to buy) | D | 0,30 | 20.000 | 20.000 | |||||
| 2019-10-28 | 2019-05-30 | 4 | WU MIJIA | NBY | Stock option (right to buy) | D | 0,30 | 20.000 | 20.000 | |||||
| 2019-10-28 | 2019-05-30 | 4 | Li Xinzhou | NBY | Stock option (right to buy) | D | 0,30 | 20.000 | 20.000 | |||||
| 2019-09-30 | 3 | Zheng Yenyou | NBY | Common Stock | D | 0 | ||||||||
| 2019-08-06 | 2019-07-30 | 4 | SIECZKAREK MARK M | NBY | Common Stock | D | 167.938 | 1.156.883 | ||||||
| 2019-06-13 | 2019-06-11 | 4 | Fu Jian Ping | NBY | common stock | D | 3,8400 | -380.954 | -1.463 | 5.302.350 | ||||
| 2019-06-13 | 2019-06-11 | 4 | Pioneer Pharma (Hong Kong) Co Ltd | NBY | Common Stock | D | 4,0400 | -24.326 | -98 | 5.188.421 | ||||
| 2019-06-13 | 2019-06-11 | 4 | WU MIJIA Spouse | NBY | Common Stock | I | 4,0400 | -15.873 | -64 | 0 | ||||
| 2019-06-13 | 2019-06-10 | 4 | WU MIJIA | NBY | Common Stock | D | 2,0300 | -47.619 | -97 | 0 | ||||
| 2019-06-12 | 2019-06-11 | 4 | Raleigh Jason Philip | NBY | stock option | D | 2,35 | -9.750 | 0 | |||||
| 2019-06-12 | 2019-06-10 | 4 | Raleigh Jason Philip | NBY | stock option | D | 2,20 | -23.405 | 0 | |||||
| 2019-06-12 | 2019-06-10 | 4 | Hall Justin | NBY | stock option | D | 2,02 | -47.500 | 0 | |||||
| 2019-03-26 | 3 | Raleigh Jason Philip | NBY | Common Stock | D | 0 | ||||||||
| 2018-10-11 | 2018-10-09 | 4 | McGovern John Joseph | NBY | Stock option (right to buy) | D | 1,45 | 250.000 | 440.000 | |||||
| 2018-06-04 | 2018-05-31 | 4 | Zavodnick Todd Erik | NBY | Stock Option (right to buy) | D | 2,20 | 20.000 | 53.698 | |||||
| 2018-06-04 | 2018-05-31 | 4 | WU MIJIA | NBY | Stock Option (right to buy) | D | 2,20 | 20.000 | 35.244 | |||||
| 2018-06-04 | 2018-05-31 | 4 | Maderis Gail J | NBY | Stock Option (right to buy) | D | 2,20 | 20.000 | 84.213 | |||||
| 2018-06-04 | 2018-05-31 | 4 | Ma Yonghao | NBY | Stock Option (right to buy) | D | 2,20 | 20.000 | 43.629 | |||||
| 2018-06-04 | 2018-05-31 | 4 | Li Xinzhou | NBY | Stock Option (right to buy) | D | 2,20 | 20.000 | 25.248 | |||||
| 2018-06-04 | 2018-05-31 | 4 | Liu Yanbin | NBY | Stock Option (right to buy) | D | 2,20 | 20.000 | 20.000 | |||||
| 2018-06-04 | 2018-05-31 | 4 | Freiman Paul E. | NBY | Stock Option (right to buy) | D | 2,20 | 20.000 | 62.697 | |||||
| 2018-06-01 | 2018-05-31 | 4 | Hall Justin | NBY | Stock Option (right to buy) | D | 2,20 | 190.000 | 345.710 | |||||
| 2018-06-01 | 2018-05-31 | 4 | McGovern John Joseph | NBY | Stock Option (right to buy) | D | 2,20 | 90.000 | 190.000 | |||||
| 2018-05-15 | 3 | Liu Yanbin | NBY | Common Stock | D | 0 | ||||||||
| 2018-01-19 | 2017-01-03 | 4/A | Ma Yonghao | NBY | stock option (right to buy) | D | 3,24 | 20.326 | 23.629 | |||||
| 2018-01-08 | 3 | STUART LEWIS J | NBY | Common Stock | D | 0 | ||||||||
| 2018-01-08 | 2017-12-14 | 4 | STUART LEWIS J | NBY | Restricted Stock Unit | D | 3,42 | 10.000 | 10.000 | |||||
| 2018-01-08 | 2017-12-14 | 4 | STUART LEWIS J | NBY | stock option (right to buy) | D | 3,42 | 100.000 | 100.000 | |||||
| 2017-09-18 | 2017-09-14 | 4 | Hall Justin | NBY | stock option | D | 2,78 | -20.000 | 278.160 | |||||
| 2017-08-01 | 3 | McGovern John Joseph | NBY | Common Stock | D | 0 | ||||||||
| 2017-08-01 | 2017-07-17 | 4 | McGovern John Joseph | NBY | Stock option (right to buy) | D | 3,80 | 100.000 | 100.000 | |||||
| 2017-07-07 | 2017-07-03 | 4 | Li Xinzhou | NBY | stock option (right to buy) | D | 3,75 | 5.248 | 5.248 | |||||
| 2017-06-06 | 2017-06-02 | 4 | SIECZKAREK MARK M | NBY | stock option (right to buy) | D | 2,35 | 250.000 | 250.000 | |||||
| 2017-01-26 | 2017-01-25 | 4 | SIECZKAREK MARK M | NBY | stock option (right to buy) | D | 3,60 | 238.609 | 936.857 | |||||
| 2017-01-26 | 2017-01-25 | 4 | PAULSON THOMAS J | NBY | stock option (right to buy) | D | 3,60 | 116.000 | 310.788 | |||||
| 2017-01-26 | 2017-01-25 | 4 | Hall Justin | NBY | stock option (right to buy) | D | 3,60 | 143.000 | 278.160 | |||||
| 2017-01-04 | 2017-01-03 | 4 | Freiman Paul E. | NBY | stock option (right to buy) | D | 3,24 | 25.916 | 67.097 | |||||
| 2017-01-04 | 2017-01-03 | 4 | Freiman Paul E. | NBY | stock option (right to buy) | D | 3,24 | 25.916 | 67.097 | |||||
| 2017-01-04 | 2017-01-03 | 4 | Maderis Gail J | NBY | stock option (right to buy) | D | 3,24 | 23.883 | 59.769 | |||||
| 2017-01-04 | 2017-01-03 | 4 | Zavodnick Todd Erik | NBY | stock option (right to buy) | D | 3,24 | 22.359 | 33.699 | |||||
| 2017-01-04 | 2017-01-03 | 4 | WU MIJIA | NBY | stock option (right to buy) | D | 3,24 | 15.245 | 15.245 | |||||
| 2017-01-04 | 2017-01-03 | 4 | LIU XIAOYAN | NBY | stock option (right to buy) | D | 3,24 | 15.245 | 15.245 | |||||
| 2017-01-04 | 2017-01-03 | 4 | Ma Yonghao | NBY | stock option (right to buy) | D | 3,24 | 33.699 | 37.002 | |||||
| 2016-10-11 | 2016-10-11 | 4 | Fu Jian Ping | NBY | Common Stock | D | 3,1500 | 126.985 | 400 | 3.983.304 | ||||
| 2016-10-04 | 2016-10-03 | 4/A | Zavodnick Todd Erik | NBY | Stock Option (right to buy) | D | 3,99 | 247 | 11.367 | |||||
| 2016-10-04 | 2016-10-03 | 4 | Zavodnick Todd Erik | NBY | Stock Option (right to buy) | D | 3,99 | 3.303 | 14.396 | |||||
| 2016-10-04 | 2016-10-03 | 4 | Ma Yonghao | NBY | Stock Option (right to buy) | D | 3,99 | 3.303 | 3.303 | |||||
| 2016-10-03 | 2016-09-30 | 4 | SIECZKAREK MARK M | NBY | Common Stock | D | 1,9100 | 273.447 | 522 | 988.945 | ||||
| 2016-10-03 | 2016-09-30 | 4 | WU MIJIA | NBY | Common Stock | D | 3,1500 | 15.873 | 50 | 47.619 | ||||
| 2016-09-26 | 2016-09-22 | 4 | Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Common Stock | D | 1,8100 | 181.300 | 328 | 3.879.519 | ||||
| 2016-09-26 | 2016-09-22 | 4 | Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Common Stock | D | 1,9100 | 1.308.902 | 2.500 | 5.188.421 | ||||
| 2016-09-26 | 2016-09-22 | 4 | Fu Jian Ping | NBY | Common Stock | D | 1,9100 | 968.587 | 1.850 | 3.856.319 | ||||
| 2016-09-01 | 3 | Ma Yonghao | NBY | NBY | D | 0 | ||||||||
| 2016-08-02 | 2016-08-01 | 4 | SIECZKAREK MARK M | NBY | Warrant | D | 1,91 | 130.890 | 273.447 | |||||
| 2016-08-02 | 2016-08-01 | 4 | SIECZKAREK MARK M | NBY | Common Stock | D | 1,9100 | 261.780 | 500 | 715.498 | ||||
| 2016-08-02 | 2016-08-01 | 4 | Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Warrant | D | 1,91 | 654.451 | 1.490.202 | |||||
| 2016-08-02 | 2016-08-01 | 4 | Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Common Stock | D | 1,9100 | 1.308.901 | 2.500 | 3.698.219 | ||||
| 2016-07-01 | 2016-07-01 | 4 | Zavodnick Todd Erik | NBY | stock option (right to buy) | D | 2,58 | 11.093 | 0 | |||||
| 2016-06-09 | 2016-06-06 | 4 | Hall Justin | NBY | stock option (right to buy) | D | 2,78 | 130.000 | 135.160 | |||||
| 2016-06-08 | 2016-06-06 | 4 | SIECZKAREK MARK M | NBY | stock option (right to buy) | D | 2,78 | 675.000 | 698.248 | |||||
| 2016-06-08 | 2016-06-06 | 4 | PAULSON THOMAS J | NBY | stock option (right to buy) | D | 2,78 | 160.000 | 194.788 | |||||
| 2016-05-16 | 2016-05-09 | 4 | Fu Jian Ping | NBY | Warrant | D | 1,91 | 968.587 | 1.095.572 | |||||
| 2016-05-16 | 2016-05-09 | 4 | Fu Jian Ping | NBY | Common Stock | D | 1,9100 | 1.937.173 | 3.700 | 2.887.732 | ||||
| 2016-05-13 | 2016-05-09 | 4 | SIECZKAREK MARK M | NBY | Common Stock | D | 1,9100 | 261.780 | 500 | 453.718 | ||||
| 2016-05-13 | 2016-05-09 | 4 | SIECZKAREK MARK M | NBY | Warrant | D | 1,91 | 130.890 | 142.557 | |||||
| 2016-05-13 | 2016-05-09 | 4 | Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Warrant | D | 1,91 | 654.451 | 835.751 | |||||
| 2016-05-13 | 2016-05-09 | 4 | Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Common Stock | D | 1,9100 | 1.308.901 | 2.500 | 2.389.318 | ||||
| 2016-05-10 | 3 | Zavodnick Todd Erik | NBY | NBY | D | 0 | ||||||||
| 2016-03-09 | 2016-03-09 | 4 | SIECZKAREK MARK M | NBY | Restricted Stock Units | D | 58.692 | 58.692 | ||||||
| 2016-03-09 | 2016-03-09 | 4 | Hall Justin | NBY | Restricted Stock Unit | D | 5.000 | 2.400 | ||||||
| 2016-03-04 | 3 | Fu Jian Ping | NBY | Common Stock | D | 1.901.118 | ||||||||
| 2016-03-04 | 3 | Fu Jian Ping | NBY | Common Stock | D | 1.901.118 | ||||||||
| 2016-02-26 | 2016-02-25 | 4 | SIECZKAREK MARK M | NBY | Common Stock | D | 1,9100 | 125.387 | 239 | 133.246 | ||||
| 2016-02-26 | 2016-02-25 | 4 | Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Common Stock | D | 1,9100 | 696.590 | 1.330 | 1.104.742 | ||||
| 2016-02-01 | 3 | LIU XIAOYAN | NBY | No securities are beneficially owned. | D | 0 | ||||||||
| 2016-02-01 | 3 | WU MIJIA | NBY | Common Stock | D | 63.492 | ||||||||
| 2016-02-01 | 3 | WU MIJIA | NBY | Common Stock | D | 63.492 | ||||||||
| 2016-01-08 | 3 | Hall Justin | NBY | Common Stock | D | 800 | ||||||||
| 2016-01-08 | 3 | Hall Justin | NBY | Common Stock | D | 800 | ||||||||
| 2016-01-06 | 2016-01-04 | 4 | Radaelli Massimo | NBY | Common Stock (right to buy) | D | 2,02 | 600 | 2.400 | |||||
| 2016-01-06 | 2016-01-04 | 4 | Maderis Gail J | NBY | Stock Option (right to buy) | D | 2,02 | 24.777 | 35.886 | |||||
| 2016-01-06 | 2016-01-04 | 4 | McPherson T. Alex | NBY | Common Stock (right to buy) | D | 2,02 | 22.719 | 44.210 | |||||
| 2016-01-06 | 2016-01-04 | 4 | Freiman Paul E. | NBY | Stock Option (right to buy) | D | 2,02 | 26.835 | 41.181 | |||||
| 2016-01-06 | 2016-01-04 | 4 | SIECZKAREK MARK M | NBY | Stock Option (right to buy) | D | 2,02 | 16.032 | 23.246 | |||||
| 2015-10-06 | 2015-10-05 | 4 | Stroman David W. | NBY | Option (right to buy) | D | 0,27 | 100.000 | 474.834 | |||||
| 2015-10-06 | 2015-10-05 | 4 | PAULSON THOMAS J | NBY | Option (right to buy) | D | 0,27 | 150.000 | 869.675 | |||||
| 2015-10-06 | 2015-10-05 | 4 | PAULSON THOMAS J | NBY | Restricted Stock Unit | D | 50.000 | 142.196 | ||||||
| 2015-10-06 | 2015-10-05 | 4 | WU ROY J | NBY | Restricted Stock Unit | D | 0,00 | 25.000 | 25.000 | |||||
| 2015-10-06 | 2015-10-05 | 4 | WU ROY J | NBY | Option (right to buy) | D | 0,27 | 150.000 | 614.725 | |||||
| 2015-08-21 | 2015-08-20 | 4 | Najafi Ramin Individual Retirement Account | NBY | Common Stock | I | 0,4400 | 6.000 | 3 | 12.000 | ||||
| 2015-08-21 | 2015-08-19 | 4 | Najafi Ramin Individual Retirement Account | NBY | Common Stock | I | 0,5000 | 6.000 | 3 | 6.000 | ||||
| 2015-06-16 | 2015-06-12 | 4 | SIECZKAREK MARK M | NBY | Stock Option (right to buy) | D | 0,79 | 24.128 | 180.362 | |||||
| 2015-04-30 | 2015-04-14 | 4/A | Hoon Russell A. | NBY | Common Stock | D | 4.515 | 34.217 | ||||||
| 2015-04-15 | 2015-04-14 | 4 | Hoon Russell A. | NBY | Restricted Stock Unit | D | 4.515 | 34.217 | ||||||
| 2015-03-25 | 2015-03-23 | 4 | PAULSON THOMAS J | NBY | Restricted Stock Unit | D | 23.986 | 92.196 | ||||||
| 2015-03-25 | 2015-03-23 | 4 | WU ROY J | NBY | Restricted Stock Unit | D | 19.296 | 19.296 | ||||||
| 2015-03-25 | 2015-03-23 | 4 | Najafi Ramin Ownership through the Najafi Family Trust | NBY | Restricted Stock Unit | I | 46.033 | 3.437.699 | ||||||
| 2015-03-05 | 2015-03-03 | 4 | SIECZKAREK MARK M | NBY | Warrant | D | 0,65 | 0,6500 | 124.999 | 81 | 291.665 | |||
| 2015-03-05 | 2015-03-03 | 4 | SIECZKAREK MARK M | NBY | Warrant | D | 0,60 | 0,6000 | 166.666 | 100 | 291.665 | |||
| 2015-03-05 | 2015-03-03 | 4 | SIECZKAREK MARK M | NBY | Common Stock | D | 0,6000 | 166.666 | 100 | 196.466 | ||||
| 2015-03-05 | 2015-03-03 | 4 | Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Warrant | D | 0,65 | 0,6500 | 1.942.500 | 1.263 | 4.532.500 | |||
| 2015-03-05 | 2015-03-03 | 4 | Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Warrant | D | 0,60 | 0,6000 | 2.590.000 | 1.554 | 4.532.500 | |||
| 2015-03-05 | 2015-03-03 | 4 | Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Common Stock | D | 0,6000 | 2.590.000 | 1.554 | 9.595.656 | ||||
| 2015-03-05 | 2015-03-03 | 4 | Najafi Ramin Ownership through the Najafi Family Trust | NBY | Warrant | I | 0,65 | 0,6500 | 124.999 | 81 | 291.665 | |||
| 2015-03-05 | 2015-03-03 | 4 | Najafi Ramin Ownership through the Najafi Family Trust | NBY | Warrant | I | 0,60 | 0,6000 | 166.666 | 100 | 291.665 | |||
| 2015-03-05 | 2015-03-03 | 4 | Najafi Ramin Ownership through the Najafi Family Trust | NBY | Common Stock | I | 0,6000 | 166.666 | 100 | 3.391.666 | ||||
| 2015-01-06 | 2015-01-02 | 4 | Cashion Charles | NBY | Stock Option (right to buy) | D | 0,64 | 69.368 | 377.156 | |||||
| 2015-01-06 | 2015-01-02 | 4 | McPherson T. Alex | NBY | Stock Option (right to buy) | D | 0,64 | 144.444 | 537.279 | |||||
| 2015-01-06 | 2015-01-02 | 4 | Radaelli Massimo | NBY | Stock Option (right to buy) | D | 0,64 | 15.000 | 45.000 | |||||
| 2015-01-06 | 2015-01-02 | 4 | SIECZKAREK MARK M | NBY | Stock Option (right to buy) | D | 0,64 | 92.667 | 156.234 | |||||
| 2015-01-06 | 2015-01-02 | 4 | Maderis Gail J | NBY | Stock Option (right to buy) | D | 0,64 | 121.144 | 277.726 | |||||
| 2015-01-06 | 2015-01-02 | 4 | Freiman Paul E. | NBY | Stock Option (right to buy) | D | 0,64 | 121.144 | 358.654 | |||||
| 2015-01-06 | 2015-01-02 | 4 | Wicks Tony D.S. | NBY | Stock Option (right to buy) | D | 0,64 | 15.000 | 301.016 | |||||
| 2014-12-24 | 3 | Hoon Russell A. | NBY | Restricted Stock Unit | D | 59.404 | ||||||||
| 2014-12-24 | 3 | Hoon Russell A. | NBY | Restricted Stock Unit | D | 59.404 | ||||||||
| 2014-12-16 | 2014-12-12 | 4 | Stroman David W. | NBY | Common Stock | D | 0,6600 | 10.000 | 7 | 23.000 | ||||
| 2014-12-15 | 2014-12-12 | 4 | Najafi Ramin | NBY | Common Stock | D | 0,6500 | 50.000 | 32 | 0 | ||||
| 2014-12-15 | 2014-12-12 | 4 | PAULSON THOMAS J | NBY | Common Stock | D | 0,6800 | 10.000 | 7 | 68.210 | ||||
| 2014-12-11 | 2014-12-09 | 4 | PAULSON THOMAS J | NBY | Common Stock | D | 0,6700 | 10.000 | 7 | 58.210 | ||||
| 2014-12-11 | 2014-12-11 | 4 | Najafi Ramin | NBY | Common Stock | D | 0,6000 | 20.000 | 12 | 3.175.000 | ||||
| 2014-12-08 | 2014-12-05 | 4 | Najafi Ramin | NBY | Common Stock | D | 0,6500 | 25.000 | 16 | 3.155.000 | ||||
| 2014-12-04 | 2014-12-02 | 4 | Najafi Ramin | NBY | Common Stock | D | 0,7100 | 18.000 | 13 | 3.130.000 | ||||
| 2014-12-04 | 2014-12-02 | 4 | Wicks Tony D.S. | NBY | Common Stock | D | 0,7000 | -20.000 | -14 | 0 | ||||
| 2014-12-03 | 2014-12-01 | 4 | Wicks Tony D.S. | NBY | Common Stock | D | 0,6900 | -10.000 | -7 | 213.680 | ||||
| 2014-09-30 | 2014-09-26 | 4 | Stroman David W. | NBY | Option (right to buy) | D | 0,75 | 50.000 | 374.834 | |||||
| 2014-09-30 | 2014-09-26 | 4 | Najafi Ramin | NBY | Option (right to buy) | D | 0,75 | 90.000 | 1.015.032 | |||||
| 2014-09-30 | 2014-09-26 | 4 | Bley Keith R | NBY | Option (right to buy) | D | 0,75 | 50.000 | 258.120 | |||||
| 2014-09-30 | 2014-09-26 | 4 | PAULSON THOMAS J | NBY | Option (right to buy) | D | 0,75 | 60.000 | 719.675 | |||||
| 2014-09-30 | 2014-09-26 | 4 | WU ROY J | NBY | Option (right to buy) | D | 0,75 | 50.000 | 464.725 | |||||
| 2014-06-05 | 2014-06-04 | 4 | SIECZKAREK MARK M | NBY | Common Stock | D | 0,8900 | 4.800 | 4 | 29.800 | ||||
| 2014-06-04 | 2014-06-02 | 4 | Najafi Ramin Najafi Family Trust | NBY | Common Stock | I | -5.500 | 3.112.000 | ||||||
| 2014-05-21 | 2014-05-19 | 4 | SIECZKAREK MARK M | NBY | Common Stock | D | 0,8800 | 25.000 | 22 | 25.000 | ||||
| 2014-05-14 | 2014-05-09 | 4 | China Pioneer Pharma Holdings Ltd | NBY | Common Stock | D | 0,9900 | 318.828 | 316 | 426.984 | ||||
| 2014-05-14 | 2014-05-12 | 4 | China Pioneer Pharma Holdings Ltd | NBY | Common Stock | D | 0,9900 | 116.107 | 115 | 543.091 | ||||
| 2014-05-14 | 2014-05-13 | 4 | China Pioneer Pharma Holdings Ltd | NBY | Common Stock | D | 0,9900 | 65.065 | 64 | 608.156 | ||||
| 2014-04-17 | 2014-04-15 | 4 | WU ROY J | NBY | Option (right to buy) | D | 1,00 | 7.823 | 414.725 | |||||
| 2014-04-17 | 2014-04-15 | 4 | PAULSON THOMAS J | NBY | Option (right to buy) | D | 1,00 | 9.866 | 699.675 | |||||
| 2014-04-17 | 2014-04-15 | 4 | Bley Keith R | NBY | Option (right to buy) | D | 1,00 | 7.120 | 208.120 | |||||
| 2014-04-17 | 2014-04-15 | 4 | Najafi Ramin | NBY | Option (right to buy) | D | 1,00 | 10.180 | 925.032 | |||||
| 2014-04-17 | 2014-04-15 | 4 | Stroman David W. | NBY | Option (right to buy) | D | 1,00 | 5.011 | 324.834 | |||||
| 2014-04-14 | 2014-04-14 | 4 | Wicks Tony D.S. | NBY | Option (right to buy) | D | 0,56 | -52.000 | 234.068 | |||||
| 2014-04-14 | 2014-04-14 | 4 | Wicks Tony D.S. | NBY | Common Stock | D | 0,5600 | 52.000 | 29 | 213.690 | ||||
| 2014-03-21 | 2014-03-17 | 4 | Dailley Anthony | NBY | Option (right to buy) | D | 0,56 | -9.000 | 191.967 | |||||
| 2014-03-21 | 2014-03-17 | 4 | Dailley Anthony | NBY | Common Stock | D | 0,5600 | 9.000 | 5 | 285.259 | ||||
| 2014-01-31 | 2014-01-30 | 4 | SIECZKAREK MARK M | NBY | Option (right to buy) | D | 1,14 | 33.567 | 63.567 | |||||
| 2014-01-31 | 2014-01-30 | 4 | Wicks Tony D.S. | NBY | Option (right to buy) | D | 1,14 | 14.919 | 286.068 | |||||
| 2014-01-31 | 2014-01-30 | 4 | Tufts Robert R. | NBY | Option (right to buy) | D | 1,14 | 30.583 | 191.468 | |||||
| 2014-01-31 | 2014-01-30 | 4 | Cashion Charles | NBY | Option (right to buy) | D | 1,14 | 31.329 | 307.788 | |||||
| 2014-01-31 | 2014-01-30 | 4 | McPherson T. Alex | NBY | Option (right to buy) | D | 1,14 | 86.528 | 382.335 | |||||
| 2014-01-31 | 2014-01-30 | 4 | Maderis Gail J | NBY | Option (right to buy) | D | 1,14 | 61.167 | 267.631 | |||||
| 2014-01-09 | 2014-01-09 | 4 | SIECZKAREK MARK M | NBY | Option (right to buy) | D | 1,25 | 30.000 | 30.000 | |||||
| 2014-01-09 | 2014-01-02 | 4 | Wicks Tony D.S. | NBY | Option (right to buy) | D | 1,29 | 15.000 | 271.149 | |||||
| 2014-01-09 | 2014-01-02 | 4 | Freiman Paul E. | NBY | Option (right to buy) | D | 1,29 | 15.000 | 237.510 | |||||
| 2014-01-09 | 2014-01-02 | 4 | Tufts Robert R. | NBY | Option (right to buy) | D | 1,29 | 15.000 | 160.885 | |||||
| 2014-01-09 | 2014-01-02 | 4 | Dailley Anthony | NBY | Option (right to buy) | D | 1,29 | 15.000 | 203.217 | |||||
| 2014-01-09 | 2014-01-02 | 4 | Cashion Charles | NBY | Option (right to buy) | D | 1,29 | 15.000 | 276.459 | |||||
| 2014-01-09 | 2014-01-02 | 4 | McPherson T. Alex | NBY | Option (right to buy) | D | 1,29 | 15.000 | 295.807 | |||||
| 2014-01-09 | 2014-01-09 | 4 | Radaelli Massimo | NBY | Option (right to buy) | D | 1,25 | 30.000 | 30.000 | |||||
| 2014-01-09 | 2014-01-02 | 4 | Maderis Gail J | NBY | Option (right to buy) | D | 1,29 | 15.000 | 206.464 | |||||
| 2013-12-04 | 2013-12-02 | 4 | Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Common Stock Purchase Warrant (Right to Buy) | D | 1,50 | -1.200.000 | 0 | |||||
| 2013-12-04 | 2013-12-02 | 4 | Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Common Stock Purchase Warrant (Right to Buy) | D | 1,50 | -800.000 | 0 | |||||
| 2013-12-04 | 2013-12-02 | 4 | Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Common Stock | D | 1,1400 | 5.000.000 | 5.700 | 7.005.656 | ||||
| 2013-12-04 | 2013-12-02 | 4 | China Pioneer Pharma Holdings Ltd By Pioneer Pharma (Singapore)Pte. Ltd. | NBY | Common Stock Purchase Warrant (Right to Buy) | I | 1,50 | -1.200.000 | 0 | |||||
| 2013-12-04 | 2013-12-02 | 4 | China Pioneer Pharma Holdings Ltd By Pioneer Pharma (Singapore)Pte. Ltd. | NBY | Common Stock Purchase Warrant (Right to Buy) | I | 1,50 | -800.000 | 0 | |||||
| 2013-12-04 | 2013-12-02 | 4 | China Pioneer Pharma Holdings Ltd By Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Common Stock | I | 1,1400 | 5.000.000 | 5.700 | 7.005.656 | ||||
| 2013-12-04 | 2013-12-02 | 4 | Pioneer Pharma (Hong Kong) Co Ltd By Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Common Stock Purchase Warrant (Right to Buy) | I | 1,50 | -1.200.000 | 0 | |||||
| 2013-12-04 | 2013-12-02 | 4 | Pioneer Pharma (Hong Kong) Co Ltd By Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Common Stock Purchase Warrant (Right to Buy) | I | 1,50 | -800.000 | 0 | |||||
| 2013-12-04 | 2013-12-02 | 4 | Pioneer Pharma (Hong Kong) Co Ltd By Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Common Stock | I | 1,1400 | 5.000.000 | 5.700 | 7.005.656 | ||||
| 2013-12-02 | 2013-07-22 | 4 | Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Common Stock | D | 3.913 | 2.005.656 | ||||||
| 2013-12-02 | 2013-04-29 | 4 | Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Common Stock | D | 1.743 | 2.001.743 | ||||||
| 2013-12-02 | 2013-04-29 | 4 | Li Xinzhou By Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Common Stock | I | 1.743 | 2.001.743 | ||||||
| 2013-12-02 | 2013-09-20 | 4 | Li Xinzhou | NBY | Common Stock | D | 1,8749 | -120.000 | -225 | 0 | ||||
| 2013-12-02 | 3 | China Pioneer Pharma Holdings Ltd By Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Common Stock | I | 2.001.743 | ||||||||
| 2013-12-02 | 2013-11-14 | 4 | China Pioneer Pharma Holdings Ltd | NBY | Common Stock | D | 1,0200 | 108.156 | 110 | 108.156 | ||||
| 2013-12-02 | 2013-07-22 | 4 | China Pioneer Pharma Holdings Ltd By Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Common Stock | I | 3.913 | 2.005.656 | ||||||
| 2013-12-02 | 3 | Pioneer Pharma (Hong Kong) Co Ltd By Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Common Stock | I | 2.001.743 | ||||||||
| 2013-12-02 | 2013-07-22 | 4 | Pioneer Pharma (Hong Kong) Co Ltd By Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Common Stock | I | 3.913 | 2.005.656 | ||||||
| 2013-10-29 | 2013-10-28 | 4 | PAULSON THOMAS J | NBY | Common Stock | D | 1,7500 | -3.645 | -6 | 63.855 | ||||
| 2013-10-29 | 2013-10-28 | 4 | Najafi Ramin | NBY | Common Stock | D | 1,7500 | -4.557 | -8 | 100.195 | ||||
| 2013-10-02 | 2013-09-26 | 4 | PAULSON THOMAS J | NBY | Option (right to buy) | D | 1,71 | -110.000 | 689.809 | |||||
| 2013-10-02 | 2013-09-26 | 4 | WU ROY J | NBY | Option (right to buy) | D | 1,71 | 62.000 | 406.902 | |||||
| 2013-10-02 | 2013-09-26 | 4 | Bley Keith R | NBY | Option (right to buy) | D | 1,71 | 51.000 | 201.000 | |||||
| 2013-10-02 | 2013-09-26 | 4 | Najafi Ramin | NBY | Option (right to buy) | D | 1,71 | -150.000 | 914.852 | |||||
| 2013-10-02 | 2013-09-26 | 4 | Stroman David W. | NBY | Option (right to buy) | D | 1,71 | -62.000 | 319.823 | |||||
| 2013-03-06 | 2013-03-05 | 4 | Bley Keith R | NBY | Options (right to buy) | D | 1,15 | 150.000 | 150.000 | |||||
| 2013-02-01 | 2013-01-30 | 4 | Wicks Tony D.S. | NBY | Options (right to buy) | D | 1,29 | 19.603 | 256.149 | |||||
| 2013-02-01 | 2013-01-30 | 4 | Cashion Charles | NBY | Option (right to buy) | D | 1,29 | 19.603 | 261.459 | |||||
| 2013-02-01 | 2013-01-30 | 4 | McPherson T. Alex | NBY | option (right to buy) | D | 1,29 | 39.205 | 280.807 | |||||
| 2013-02-01 | 2013-01-30 | 4 | Maderis Gail J | NBY | Option (right to buy) | D | 1,29 | 39.205 | 191.464 | |||||
| 2013-01-15 | 2013-01-02 | 4 | Wicks Tony D.S. | NBY | Option (right to buy) | D | 1,13 | 15.000 | 236.546 | |||||
| 2013-01-15 | 2013-01-02 | 4 | Freiman Paul E. | NBY | Option (right to buy) | D | 1,13 | 15.000 | 222.510 | |||||
| 2013-01-15 | 2013-01-02 | 4 | Tufts Robert R. | NBY | Option (right to buy) | D | 1,13 | 15.000 | 145.885 | |||||
| 2013-01-15 | 2013-01-02 | 4 | Dailley Anthony | NBY | Option (right to buy) | D | 1,13 | 15.000 | 188.217 | |||||
| 2013-01-15 | 2013-01-02 | 4 | Cashion Charles | NBY | Option (right to buy) | D | 1,13 | 15.000 | 241.856 | |||||
| 2013-01-15 | 2013-01-02 | 4 | McPherson T. Alex | NBY | Option (right to buy) | D | 1,13 | 15.000 | 241.602 | |||||
| 2013-01-15 | 2013-01-02 | 4 | Maderis Gail J | NBY | Option (right to buy) | D | 1,13 | 15.000 | 152.259 | |||||
| 2013-01-14 | 2013-01-10 | 4 | PAULSON THOMAS J | NBY | Option (right to buy) | D | 1,13 | 25.000 | 579.809 | |||||
| 2013-01-14 | 2013-01-10 | 4 | WU ROY J | NBY | Option (right to buy) | D | 1,13 | 25.000 | 344.902 | |||||
| 2013-01-14 | 2013-01-10 | 4 | Khosrovi Behzad | NBY | Option (right to buy) | D | 1,13 | 25.000 | 536.283 | |||||
| 2013-01-14 | 2013-01-10 | 4 | Najafi Ramin | NBY | Option (right to buy) | D | 1,13 | 85.000 | 764.852 | |||||
| 2013-01-14 | 2013-01-20 | 4 | Stroman David W. | NBY | Option (right to buy) | D | 1,13 | 25.000 | 257.823 | |||||
| 2013-01-03 | 2012-12-11 | 4 | Li Xinzhou | NBY | Common Stock | D | 1,2000 | 120.000 | 144 | 2.120.000 | ||||
| 2013-01-02 | 2012-09-13 | 4 | Li Xinzhou The warrants are held by Pioneer Pharma (Singapore) Pte. Ltd., a 100% wholly owned subsidiary of Naq | NBY | Warrant | I | 1,50 | 1,5000 | 800.000 | 1.200 | 800.000 | |||
| 2013-01-02 | 2012-09-13 | 4 | Li Xinzhou The shares are held by Pioneer Pharma (Singapore) Pte. Ltd., a 100% wholly owned subsidiary of Naqu | NBY | Common Stock | I | 1,2500 | 800.000 | 1.000 | 800.000 | ||||
| 2013-01-02 | 3 | Li Xinzhou The shares are held by Pioneer Pharma (Singapore) Pte. Ltd., a 100% wholly owned subsidiary of Naqu | NBY | Common Stock | I | 800.000 | ||||||||
| 2013-01-02 | 2012-10-31 | 4 | Li Xinzhou The warrants are held by Pioneer Pharma (Singapore) Pte. Ltd., a 100% wholly owned subsidiary of Naq | NBY | Warrant | I | 1,50 | 1,5000 | 1.200.000 | 1.800 | 2.000.000 | |||
| 2013-01-02 | 2012-10-31 | 4 | Li Xinzhou The shares are held by Pioneer Pharma (Singapore) Pte. Ltd., a 100% wholly owned subsidiary of Naqu | NBY | Common Stock | I | 1,2500 | 1.200.000 | 1.500 | 2.000.000 | ||||
| 2012-12-10 | 2012-12-06 | 4 | PAULSON THOMAS J | NBY | warrant to purchase Common Stock | D | 1,50 | 0,0100 | 7.500 | 0 | 7.500 | |||
| 2012-12-10 | 2012-12-06 | 4 | PAULSON THOMAS J | NBY | Common Stock | D | 1,2400 | 10.000 | 12 | 63.855 | ||||
| 2012-12-10 | 2012-12-06 | 4 | Najafi Ramin | NBY | Warrants to Purchase Common Shares | D | 1,50 | 0,0100 | 15.000 | 0 | 15.000 | |||
| 2012-12-10 | 2012-12-06 | 4 | Najafi Ramin | NBY | Common Stock | D | 1,2400 | 20.000 | 25 | 100.195 | ||||
| 2012-12-10 | 2012-12-06 | 4 | Stroman David W. | NBY | Warrants to purchase Common Stock | D | 1,50 | 0,0100 | 7.500 | 0 | 7.500 | |||
| 2012-12-10 | 2012-12-06 | 4 | Stroman David W. | NBY | Common Stock | D | 1,2400 | 10.000 | 12 | 22.000 | ||||
| 2012-12-04 | 2012-10-27 | 4 | PAULSON THOMAS J | NBY | Common Stock | D | 1,3100 | -3.645 | -5 | 53.855 | ||||
| 2012-12-04 | 2012-10-27 | 4 | Najafi Ramin | NBY | Common Stock | D | 1,3100 | -4.557 | -6 | 80.195 | ||||
| 2012-11-20 | 2012-10-31 | 4 | NAQU AREA PIONEER PHARMA CO., LTD. Pioneer Pharma (Singapore) Pte. Ltd. a 100% wholly-owned subsidiary of Naqu Area Pioneer Pharma Co. | NBY | Warrant | I | 1,50 | 1,5000 | 1.200.000 | 1.800 | 2.000.000 | |||
| 2012-11-20 | 2012-10-31 | 4 | NAQU AREA PIONEER PHARMA CO., LTD. Shares are held directly by Pioneer Pharma (Singapore) Pte. Ltd. Pioneer Pharma (Singapore) Pte. Lt | NBY | Common Stock | I | 1,2500 | 1.200.000 | 1.500 | 2.000.000 | ||||
| 2012-11-20 | 3 | NAQU AREA PIONEER PHARMA CO., LTD. Pioneer Pharma (Singapore) Pte. Ltd. is a 100% wholly-owned subsidiary of Naqu Area Pioneer Pharma C | NBY | Common Stock | I | 800.000 | ||||||||
| 2012-11-05 | 2012-10-31 | 4 | Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Warrant | D | 1,50 | 1,5000 | 1.200.000 | 1.800 | 2.000.000 | |||
| 2012-11-05 | 2012-10-31 | 4 | Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Common Stock | D | 1,2500 | 1.200.000 | 1.500 | 2.000.000 | ||||
| 2012-11-05 | 3 | Pioneer Pharma (Singapore) Pte. Ltd. | NBY | Common Stock | D | 800.000 | ||||||||
| 2012-11-01 | 2012-09-26 | 4/A | PAULSON THOMAS J | NBY | Option (right to buy) | D | 1,22 | 25.000 | 554.809 | |||||
| 2012-11-01 | 2012-09-26 | 4/A | Stroman David W. | NBY | Option (right to buy) | D | 1,22 | 25.000 | 232.823 | |||||
| 2012-11-01 | 2012-09-26 | 4/A | WU ROY J | NBY | Option (right to buy) | D | 1,22 | 25.000 | 319.902 | |||||
| 2012-11-01 | 2012-09-26 | 4/A | Khosrovi Behzad | NBY | Option (right to buy) | D | 1,22 | 25.000 | 511.283 | |||||
| 2012-11-01 | 2012-09-26 | 4/A | Najafi Ramin | NBY | Option (right to buy) | D | 1,22 | 65.000 | 679.852 | |||||
| 2012-11-01 | 2012-09-27 | 4 | Tufts Robert R. | NBY | Option (right to buy) | D | 0,56 | 0,5600 | -28.500 | -16 | 0 | |||
| 2012-11-01 | 2012-09-27 | 4 | Tufts Robert R. ROBERT R TUFTS & JOYCE A TUFTS TR ROBERT & JOYCE TUFTS TRUST UA 09/18/87 | NBY | Common Stock | I | 0,5600 | 28.500 | 16 | 348.408 | ||||
| 2012-10-12 | 2012-10-10 | 4 | PAULSON THOMAS J | NBY | Option (right to buy) | D | 1,29 | 25.000 | 554.809 | |||||
| 2012-10-12 | 2012-10-10 | 4 | WU ROY J | NBY | Option (right to buy) | D | 1,29 | 25.000 | 319.902 | |||||
| 2012-10-12 | 2012-10-10 | 4 | Najafi Ramin | NBY | Option (right to buy) | D | 1,29 | 65.000 | 679.852 | |||||
| 2012-10-12 | 2012-10-10 | 4 | Khosrovi Behzad | NBY | Option (right to buy) | D | 1,29 | 25.000 | 511.283 | |||||
| 2012-10-12 | 2012-10-10 | 4 | Stroman David W. | NBY | Option (right to buy) | D | 1,29 | 25.000 | 232.823 | |||||
| 2012-05-31 | 2012-05-30 | 4 | PAULSON THOMAS J | NBY | Common Stock | D | 0,9364 | 10.000 | 9 | 17.500 | ||||
| 2012-05-30 | 2012-05-29 | 4 | Najafi Ramin | NBY | Common | D | 0,9600 | 2.000 | 2 | 34.752 | ||||
| 2012-05-30 | 2012-05-29 | 4 | Najafi Ramin | NBY | Common | D | 0,9590 | 4.000 | 4 | 32.752 | ||||
| 2012-05-29 | 2012-05-25 | 4 | Najafi Ramin | NBY | Common Stock | D | 0,9900 | 3.500 | 3 | 28.752 | ||||
| 2012-04-02 | 2007-10-25 | 5/A | Stroman David W. | NBY | Common Stock | D | 4,0000 | 2.000 | 8 | 2.000 | ||||
| 2012-02-23 | 2012-02-17 | 4 | PAULSON THOMAS J | NBY | Option (right to buy) | D | 1,44 | 54.709 | 529.809 | |||||
| 2012-02-23 | 2012-02-17 | 4 | WU ROY J | NBY | Option (Right to Buy) | D | 1,44 | 48.902 | 294.902 | |||||
| 2012-02-23 | 2012-02-17 | 4 | Khosrovi Behzad | NBY | Option (right to buy) | D | 1,44 | 52.083 | 486.283 | |||||
| 2012-02-23 | 2012-02-17 | 4 | Najafi Ramin | NBY | Option (right to purchase) | D | 1,44 | 96.652 | 614.852 | |||||
| 2012-02-23 | 2012-02-17 | 4 | Stroman David W. | NBY | Option (Right to Buy) | D | 1,44 | 7.823 | 207.823 | |||||
| 2012-02-13 | 2011-06-16 | 5 | Stroman David W. | NBY | Common Stock | D | 1,0100 | 10.000 | 10 | 10.000 | ||||
| 2012-01-05 | 2012-01-03 | 4 | Wicks Tony D.S. | NBY | Option (right to buy) | D | 1,33 | 66.230 | 66.230 | |||||
| 2012-01-05 | 2011-12-29 | 4 | Freiman Paul E. | NBY | Option (right to buy) | D | 0,20 | 0,2000 | -30.000 | -6 | 30.000 | |||
| 2012-01-05 | 2011-12-29 | 4 | Freiman Paul E. PAUL FREIMAN & ANNA MAZZUCHI FREIMAN TTEES PAUL FREIMAN & ANNA MAZZUCHI FREIMAN TR U/A DTD 5 | NBY | Common Stock | I | 0,2000 | 30.000 | 6 | 45.137 | ||||
| 2012-01-05 | 2012-01-03 | 4 | Tufts Robert R. | NBY | Option (right to buy) | D | 1,33 | 67.510 | 67.510 | |||||
| 2012-01-05 | 2012-01-03 | 4 | Freiman Paul E. | NBY | Option(right to buy) | D | 1,33 | 67.510 | 67.510 | |||||
| 2012-01-05 | 2012-01-03 | 4 | Dailley Anthony | NBY | Option (right to buy) | D | 1,33 | 66.230 | 66.230 | |||||
| 2012-01-05 | 2012-01-03 | 4 | Cashion Charles | NBY | Option (right to buy) | D | 1,33 | 68.791 | 68.791 | |||||
| 2012-01-05 | 2012-01-03 | 4 | McPherson T. Alex | NBY | Option (right to buy) | D | 1,33 | 79.037 | 79.037 | |||||
| 2012-01-05 | 2012-01-03 | 4 | Maderis Gail J | NBY | Option (right to buy) | D | 1,33 | 67.510 | 67.510 | |||||
| 2011-02-01 | 2008-09-05 | 4/A | Scott Colin | NBY | Option (right to buy) | D | 1,95 | 35.400 | 72.900 | |||||
| 2011-02-01 | 2008-09-05 | 4/A | PAULSON THOMAS J | NBY | Option (right to buy) | D | 1,95 | 44.400 | 244.400 | |||||
| 2011-02-01 | 2008-09-05 | 4/A | Khosrovi Behzad | NBY | Option (right to buy) | D | 1,95 | 35.400 | 72.900 | |||||
| 2011-01-27 | 2009-01-14 | 4/A | McPherson T. Alex | NBY | Common Stock | D | 9.084 | 28.558 | ||||||
| 2011-01-27 | 2009-01-14 | 4/A | Cashion Charles By the Charles J. Cashion and Martha Diane Cashion Trust u/d/t dated July 27, 1998 | NBY | Common Stock | I | 8.239 | 18.495 | ||||||
| 2011-01-18 | 2008-08-25 | 4/A | Tufts Robert R. By the Robert R. Tufts and Joyce A. Tufts Trust dated September 18, 1987 | NBY | Common Stock | I | 1.353 | 204.056 | ||||||
| 2011-01-18 | 2008-08-25 | 4/A | Dailley Anthony By the Anthony & Terry Dailley Trust, u/a/d 1991 | NBY | Common Stock | I | 1.353 | 146.047 | ||||||
| 2011-01-18 | 2008-08-25 | 4/A | Freiman Paul E. By the Paul Freiman and Anna Mazzuchi Freiman Trust dated 5/24/95 | NBY | Common Stock | I | 1.353 | 33.412 | ||||||
| 2011-01-18 | 2008-08-25 | 4/A | Wicks Tony D.S. By the Tony D. Wicks and Anne K. Wicks Revocable Trust | NBY | Common Stock | I | 1.353 | 140.657 | ||||||
| 2011-01-05 | 2011-01-03 | 4 | Wicks Tony D.S. | NBY | Option (right to buy) | D | 1,67 | 15.000 | 15.000 | |||||
| 2011-01-05 | 2011-01-03 | 4 | Freiman Paul E. | NBY | Option (right to buy) | D | 1,67 | 15.000 | 15.000 | |||||
| 2011-01-05 | 2011-01-03 | 4 | Tufts Robert R. | NBY | Option (right to buy) | D | 1,67 | 27.375 | 27.375 | |||||
| 2011-01-05 | 2011-01-03 | 4 | Dailley Anthony | NBY | Option (right to buy) | D | 1,67 | 15.000 | 15.000 | |||||
| 2009-10-15 | 3 | Anderson Mark Brian | NBY | Common Stock | D | 100 | ||||||||
| 2007-10-31 | 2007-10-31 | 4 | Dailley Anthony By the Anthony and Terry Dailley Trust, u/a/d 07/12/1991 | NBY | Series C Preferred Stock | I | 0,00 | -17.647 | 0 | |||||
| 2007-10-31 | 2007-10-31 | 4 | Dailley Anthony By the Anthony and Terry Dailley Trust, u/a/d 07/12/1991 | NBY | Series B Preferred Stock | I | 0,00 | -32.000 | 0 | |||||
| 2007-10-31 | 2007-10-31 | 4 | Dailley Anthony By the Anthony Dailley DDS Profit Sharing Plan | NBY | Series B Preferred Stock | I | 0,00 | -10.638 | 0 | |||||
| 2007-10-31 | 2007-10-31 | 4 | Dailley Anthony By the Anthony and Terry Dailley Trust, u/a/d 07/12/1991 | NBY | Series A Preferred Stock | I | 0,00 | -57.143 | 0 | |||||
| 2007-10-31 | 2007-10-31 | 4 | Dailley Anthony By the Anthony and Terry Dailley Trust, u/a/d 07/12/1991 | NBY | Common Stock | I | -8.823 | 138.423 | ||||||
| 2007-10-31 | 2007-10-31 | 4 | Dailley Anthony By the Anthony and Terry Dailley Trust, u/a/d 07/12/1991 | NBY | Common Stock | I | 16.000 | 129.600 | ||||||
| 2007-10-31 | 2007-10-31 | 4 | Dailley Anthony By the Anthony Dailley DDS Profit Sharing Plan | NBY | Common Stock | I | 5.319 | 7.180 | ||||||
| 2007-10-31 | 2007-10-31 | 4 | Dailley Anthony By the Anthony and Terry Dailley Trust, u/a/d 07/12/1991 | NBY | Common Stock | I | 28.572 | 113.600 | ||||||
| 2007-10-31 | 2007-10-31 | 4 | Khosrovi Behzad | NBY | Series B Preferred Stock | D | 0,00 | -200.000 | 0 | |||||
| 2007-10-31 | 2007-10-31 | 4 | Khosrovi Behzad | NBY | Common Stock | D | 100.000 | 135.000 | ||||||
| 2007-10-31 | 2007-10-31 | 4 | McPherson T. Alex | NBY | Series D Preferred Stock | D | 0,00 | -16.666 | 0 | |||||
| 2007-10-31 | 2007-10-31 | 4 | McPherson T. Alex | NBY | Common Stock | D | 8.333 | 8.333 | ||||||
| 2007-10-31 | 2007-10-31 | 4 | Tufts Robert R. By the Robert R. Tufts and Joyce A. Tufts Trust dated September 18, 1987 | NBY | Series A Preferred Stock | I | 0,00 | -142.857 | 0 | |||||
| 2007-10-31 | 2007-10-31 | 4 | Tufts Robert R. By the Robert R. Tufts and Joyce A. Tufts Trust dated September 18, 1987 | NBY | Common Stock | I | 4,0000 | 67.500 | 270 | 194.499 | ||||
| 2007-10-31 | 2007-10-31 | 4 | Tufts Robert R. By the Robert R. Tufts and Joyce A. Tufts Trust dated September 18, 1987 | NBY | Common Stock | I | 71.428 | 126.999 | ||||||
| 2007-10-31 | 2007-10-31 | 4 | Wicks Tony D.S. By the Tony D. Wicks and Anne K. Wicks Revocable Trust | NBY | Series B Preferred Stock | I | 0,00 | -30.000 | 0 | |||||
| 2007-10-31 | 2007-10-31 | 4 | Wicks Tony D.S. By the Tony D. Wicks and Anne K. Wicks Revocable Trust | NBY | Series A Preferred Stock | I | 0,00 | -71.429 | 0 | |||||
| 2007-10-31 | 2007-10-31 | 4 | Wicks Tony D.S. By the Tony D. Wicks and Anne K. Wicks Revocable Trust | NBY | Common Stock | I | 15.000 | 130.964 | ||||||
| 2007-10-31 | 2007-10-31 | 4 | Wicks Tony D.S. By the Tony D. Wicks and Anne K. Wicks Revocable Trust | NBY | Common Stock | I | 35.714 | 115.964 | ||||||
| 2007-10-24 | 3 | Najafi Family Trust dated September 13, 2006 By the Najafi Family Trust dated September 13, 2006 | NBY | Common Stock | I | 3.117.500 | ||||||||
| 2007-10-24 | 3 | Khosrovi Behzad | NBY | Common Stock | D | 35.000 | ||||||||
| 2007-10-24 | 3 | Dailley Anthony By the Anthony Dailley DDS Profit Sharing Plan | NBY | Common Stock | I | 1.861 | ||||||||
| 2007-10-24 | 3 | Dailley Anthony | NBY | Common Stock | D | 75.000 | ||||||||
| 2007-10-24 | 3 | Dailley Anthony By the Anthony and Terry Dailley Trust, u/a/d 07/12/1991 | NBY | Common Stock | I | 85.028 | ||||||||
| 2007-10-24 | 3 | Freiman Paul E. By the Paul Freiman and Anna Mazzuchi Freiman Trust | NBY | Common Stock | I | 25.000 | ||||||||
| 2007-10-24 | 3 | Tufts Robert R. By the Robert R. Tufts and Joyce A. Tufts Trust dated September 18, 1987 | NBY | Common Stock | I | 55.571 | ||||||||
| 2007-10-24 | 3 | Wicks Tony D.S. By the Tony D. Wicks and Anne K. Wicks Revocable Trust | NBY | Common Stock | I | 80.250 |
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)
